|
Freedman RA, Graff SL, Somerfield MR, Telli ML, Wolff AC, Giordano SH.
"Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A." JCO Oncology Practice, 2022, pp. OP2200140.
|
|
Subbiah IM, Markham MJ, Graff SL, Matt-Amaral LB, Close JL, Griffith KA, Jagsi R.
"Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment." Journal of Clinical Oncology, 2022, pp. JCO2102574.
|
|
Graff SL.
"People Like Us." Journal of Clinical Oncology, 2022, pp. JCO2201835.
|
|
Chidharla A, Utengen A, Attai DJ, Drake EK, van Londen GJ, Subbiah IM, Henry E, Murphy M, Barry MM, Manochakian R, Moerdler S, Loeb S, Graff SL, Leyfman Y, Thompson MA, Markham MJ.
"Social Media and Professional Development for Oncology Professionals." JCO Oncology Practice, 2022, pp. OP2100761.
|
|
Anampa-Guzmán A, Freeman-Daily J, Fisch M, Lou E, Pennell NA, Painter CA, Sparacio D, Lewis MA, Karmo M, Anderson PF, Graff SL, Collaboration for Outcomes using Social Media in Oncology.
"The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator." JCO Oncology Practice, 2022, pp. OP2100763.
|
|
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA, DESTINY-Breast03 Trial Investigators.
"Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer." New England Journal of Medicine, vol. 386, no. 12, 2022, pp. 1143-1154.
|
|
Graff SL, Wildes T, Duma N, Dizon DS, LoConte NK, Mitchell E, Murphy MC, Perez EA, Temkin SM, Kunz PL, Winkfield KM.
"Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era." Journal of Clinical Oncology, 2022, pp. JCO2201060.
|
|
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK, CLEAR Trial Investigators.
"Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma." New England Journal of Medicine, vol. 384, no. 14, 2021, pp. 1289-1300.
|
|
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A, KEYNOTE-361 Investigators.
"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial." The Lancet Oncology, vol. 22, no. 7, 2021, pp. 931-945.
|
|
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS, ASCENT Clinical Trial Investigators.
"Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer." New England Journal of Medicine, vol. 384, no. 16, 2021, pp. 1529-1541.
|
|
Denduluri N, Somerfield MR, Chavez-MacGregor M, Comander AH, Dayao Z, Eisen A, Freedman RA, Gopalakrishnan R, Graff SL, Hassett MJ, King TA, Lyman GH, Maupin GR, Nunes R, Perkins CL, Telli ML, Trudeau ME, Wolff AC, Giordano SH.
"Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update." Journal of Clinical Oncology, vol. 39, no. 6, 2021, pp. 685-693.
|
|
Graff SL.
"Treatment of Premenopausal Women: Finding the Right-Sized Endocrine Therapy." JCO Oncology Practice, 2021, pp. OP2100720.
|
|
Woitowich NC, Graff SL, Swaroop M, Jain S.
"Gender-Specific Conferences and Symposia: A Putative Support Structure for Female Physicians." Journal of Women's Health, vol. 29, no. 8, 2020, pp. 1136-1141.
|
|
Graff SL, Holder JM, Sears LE, Kurbegov D.
"Increase in Genetic Counseling and Testing Referrals After Breast Cancer Pathway Implementation." JCO Oncology Practice, vol. 16, no. 12, 2020, pp. e1481-e1488.
|
|
Ersek JL, Graff SL, Arena FP, Denduluri N, Kim ES.
"Critical Aspects of a Sustainable Clinical Research Program in the Community-Based Oncology Practice." American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, vol. 39, 2019, pp. 176-184.
|
|
Duma N, Durani U, Woods CB, Kankeu Fonkoua LA, Cook JM, Wee C, Fuentes HE, Gonzalez-Velez M, Murphy MC, Jain S, Marshall AL, Graff SL, Knoll MA.
"Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference." Journal of Clinical Oncology, vol. 37, no. 36, 2019, pp. 3538-3545.
|
|
LaCasce A, Graff S, Gao J, Close J, Boulmay B.
"Preparing Fellows for Graduation: Perspectives on Career Guidance." American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, vol. 39, 2019, pp. 609-614.
|
|
Graff SL.
"The Cattle Don't Care." Journal of Clinical Oncology, vol. 37, no. 13, 2019, pp. 1136-1138.
|
|
Cook JW, Dillmon M, Graff SL, Pentz RD, Srivastava R, Close JL.
"Caring for Colleagues and Loved Ones With Cancer." American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, vol. 38, 2018, pp. 903-908.
|
|
Graff SL, Close J, Cole S, Matt-Amaral L, Beg R, Markham MJ.
"Impact of Closed Facebook Group Participation on Female Hematology/Oncology Physicians." Journal of Oncology Practice, vol. 14, no. 12, 2018, pp. e758-e769.
|
|
Ghosh A, Sarkar S, Banerjee S, Behbod F, Tawfik O, McGregor D, Graff S, Banerjee SK.
"MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis." PLoS ONE, vol. 13, no. 5, 2018, pp. e0198143.
|
|
Gupta V, Haque I, Chakraborty J, Graff S, Banerjee S, Banerjee SK.
"Racial disparity in breast cancer: can it be mattered for prognosis and therapy." Journal of cell communication and signaling, vol. 12, no. 1, 2018, pp. 119-132.
|
|
Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH.
"Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update." Journal of Clinical Oncology, vol. 36, no. 23, 2018, pp. 2433-2443.
|
